| Literature DB >> 29290907 |
Rim Jawad1, Melroy D'souza2, Lisa Arodin Selenius1, Marita Wallenberg Lundgren1, Olof Danielsson1, Greg Nowak3, Mikael Björnstedt1, Bengt Isaksson4.
Abstract
AIM: To study the effects of warm ischemia-reperfusion (I/R) injury on hepatic morphology at the ultrastructural level and to analyze the expression of the thioredoxin (TRX) and glutaredoxin (GRX) systems.Entities:
Keywords: Electron microscopy; Glutaredoxins; Hepatic ischemia-reperfusion injury; Ischemia reperfusion injury; Oxidative stress; Portal triad clamping; Thioredoxins; Warm ischemia-reperfusion injury
Year: 2017 PMID: 29290907 PMCID: PMC5740095 DOI: 10.4254/wjh.v9.i34.1261
Source DB: PubMed Journal: World J Hepatol
Patient demographics
| P1 (M/75) | mCRC | Atypical resection | Yes | 4.39 | 2.23 | 1 | 24 (1) | 1 | 0 | 1 |
| P2 (F/71) | mCRC | Multiple resections | Yes | 23.05 | 21.93 | 2 | 53 (1) | 1 | 0 | 2 |
| P3 (M/39) | Inflammatory pseudotumor | Extended right hepatectomy | No | 4.19 | 4.81 | 1 | 41 (1) | - | - | 1 |
| P4 (M/75) | Malignant melanoma metastasis | Multiple atypical resections | Yes | 2.32 | 1.90 | 1 | 12 (2) | 1 | 0 | 1 |
| P5 (M/63) | mCRC | Bisegmentectomy | Yes | 6.25 | 7.03 | 2 | 16 (1) | 1 | 0 | 1 |
| P6 (F/78) | Carcinoid metastasis | Left hepatectomy | No | 3.73 | 2.89 | 1 | 20 (1) | 1 | 0 | 1 |
| P7 (F/61) | mCRC | Right hepatectomy | Yes | 7.14 | 6.11 | 1 | 14 (1) | 1 | 0 | 0 |
| P8 (M/55) | Malignant melanoma metastasis | Right hepatectomy | No | 7.90 | 8.84 | 2 | 48 (2) | 0 | 0 | 2 |
| P9 (M/68) | mCRC | Right hepatectomy + atypical resection | Yes | 3.85 | 1.91 | 1 | 82 (8) | 3-4 | 2 | 1 |
| P10 (M/37) | mCRC | Right hepatectomy | Yes | 6.71 | 3.96 | 2 | 33 (2) | 1 | 0 | 0 |
| P11 (M/58) | mCRC | Right hepatectomy + atypical resection | Yes | 11.16 | 9.28 | 1 | 53 (2) | 1 | 0 | 3 |
Steatosis was defined as 1: Mild (< 33%); 2: Moderate (33%-66%); 3: Severe (> 66%). Fibrosis was defined as Stage 1: Portal fibrosis; Stage 2: Periportal fibrosis; Stage 3: Septal fibrosis; and Stage 4: Cirrhosis. mCRC: Metastatic colorectal cancer.
Quantitative summary of ultrastructural changes studied by endothelial morphology, (n) patients out of total (11) patients
| Disruption of endothelium | 2/11 | 10/11 | 2/11 |
| Endothelial activation | 4/11 | 3/11 | 9/11 |
| Mitochondrial inclusions in hepatocytes | 1/11 | 6/11 | 7/11 |
| Lipids, lipofucsin | 10/11 | 10/11 | 10/11 |
Figure 1Morphological changes in liver before and after ischemia and reperfusion, transmission electron micrographs of representative images of liver sections from one patient. A: Baseline, before induction of ischemia, shows the normal state of liver morphology at a cellular level; B: Morphology of a sinusoid with neighbouring hepatocytes 20 min after ischemia; C: Representative image of sinusoid and haptocytes 20 min after reperfusion; D: Endothelial lining of a sinusoid with hepatocyte microvilli; E: Morphology of the Space of Disse post-ischemia; F: Morphology of the space of disse post-reperfusion. SD: Space of disse; H: Hepatocyte; EC: Endothelial cells; VL: Vessel lumen; K: Kupffer cell. Arrow shows the absence of hepatocyte microvilli.
Figure 2Crystalline mitochondrial inclusions. A: Baseline, before induction of ischemia, shows hepatocyte mitochondria with normal appearance; B: Post-ischemia, showing mitochondria with the crystalline inclusions and a few dilated mitochondria; C: Mitochondrial inclusions, close-up of a single mega-mitochondrion showing the inclusions post-ischemia.
Figure 3Morphometric analysis of endothelial lining. The percentage of attached endothelial lining along sinusoidal walls was quantified using network information services elements Basic Research Software. Statistical analysis was performed in Graphpad Prism, and differences were determined by the non-parametric Friedman test followed by Dunn’s post-hoc test (P < 0.01). Baseline: Before induction of ischemia; Ischemia: Twenty minutes of ischemia; Reperfusion: Twenty minutes after reperfusion.
Gene expression of redox proteins changes in mRNA expression compared to baseline, calculated using the 2-ΔΔCT method
| Ischemia | 1.09 ± 0.18 | 1.14 ± 0.30 | 1.02 ± 0.28 | 1.05 ± 0.23 | 1.19 ± 0.41 | 1.24 ± 0.46 | 1.03 ± 0.16 | 1.20 ± 0.27 | 0.83 ± 0.15 | 1.27 ± 1.24 |
| Reperfusion | 1.12 ± 0.25 | 1.31 ± 0.57 | 0.97 ± 0.33 | 1.39 ± 0.79 | 1.12 ± 0.67 | 1.16 ± 0.43 | 1.16 ± 0.26 | 1.18 ± 0.63 | 1.00 ± 0.44 | 1.22 ± 0.78 |
Figure 4Quantification of immunogold staining. Number of gold particles of 5 hepatocytes for each time point and patient were recorded. A-C: Values from the TRX immunogold staining where A: Quantification of TRX in the cytosol; B: Quantification of TRX in the nuclei; C: Total value from of TRX both in cytosol and nuclei; D-F: Values from the quantification of GRX immunogold staining where D: Quantification of GRX in the cytosol; E: Quantification of GRX in the nuclei; F: Total value of GRX both in cytosol and nuclei. Baseline: Before induction of ischemia; Ischemia: Twenty minute of ischemia; Reperfusion: Twenty minute after reperfusion.
Levels of TRX1, evaluated by immunogold staining, total number of gold particles present in five hepatocytes
| P1 | 794 | 357 | 414 |
| P2 | 310 | 202 | 323 |
| P3 | 1217 | 235 | 219 |
| P4 | 373 | 176 | 298 |
| P5 | 324 | 231 | 232 |
| P6 | 269 | 273 | 443 |
| P7 | 575 | 569 | 252 |
| P8 | 294 | 221 | 699 |
| P9 | 535 | 863 | 417 |
| P10 | 590 | 755 | 272 |